Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Many patients with relapsed or refractory acute myeloid leukemia (AML) do not receive allogeneic hematopoietic cell transplant (alloHCT) because they are unable to achieve a complete remission (CR) after reinduction chemotherapy. Starting in January 2003, we prospectively assigned patients with AML...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Chen, George L., Liu, Hong, Zhang, Yali, Thomas, Julie, Ross, Maureen, Wang, Eunice S., Block, AnneMarie W., Sait, Sheila, Deeb, George, Wallace, Paul, Wetzler, Meir, Hahn, Theresa, McCarthy, Philip L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292802/
https://ncbi.nlm.nih.gov/pubmed/24867777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.05.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller